Trial
NCT05458102
Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus Levels
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Gilead Sciences
Collaborators
—
Condition
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Intervention
Vesatolimod
Why stopped
Sponsor's decision to change the clinical development plan of this molecule. This decision is not based on efficacy or safety concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-12-03